Thorne Healthtech, Inc. (THRN) News

Thorne Healthtech, Inc. (THRN): $10.19

0.01 (-0.10%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

C

Add THRN to Watchlist
Sign Up

Industry: Food Makers

Industry

C

Ranked

#42 of 80

in industry

Filter THRN News Items

THRN News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

THRN News Highlights

  • For THRN, its 30 day story count is now at 2.
  • Over the past 3 days, the trend for THRN's stories per day has been choppy and unclear. It has oscillated between 1 and 1.

Latest THRN News From Around the Web

Below are the latest news stories about THORNE HEALTHTECH INC that investors may wish to consider to help them evaluate THRN as an investment opportunity.

L Catterton Completes Acquisition of Thorne HealthTech, Inc.

L Catterton, a leading global consumer-focused investment firm, today announced the successful completion of its acquisition of Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness.

Yahoo | October 16, 2023

L Catterton and Thorne HealthTech, Inc. Announce Expiration of Tender Offer

L Catterton and Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN) today announced that the tender offer to purchase all of the issued and outstanding shares of Thorne's common stock ("Shares") for $10.20 per Share, net to the seller in cash, without interest and less any required withholding taxes (the "Offer"), expired as scheduled at one minute past 11:59 p.m., Eastern Time, on October 12, 2023 and was not extended (such date and time, the "Expiration Time").

Yahoo | October 13, 2023

Should You Be Adding Thorne HealthTech (NASDAQ:THRN) To Your Watchlist Today?

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Yahoo | September 19, 2023

Thorne HealthTech, Inc. Enters into Definitive Agreement to be Acquired by L Catterton for $10.20 Per Share in Cash

Thorne HealthTech, Inc. ("Thorne" or the "Company") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it has entered into a definitive agreement under which L Catterton, a leading global consumer-focused investment firm, will commence a tender offer to acquire all outstanding shares of common stock of Thorne for $10.20 per share in cash. The transaction value of approximately $680 million represents a 94% premium

Yahoo | August 28, 2023

Investing in Thorne HealthTech (NASDAQ:THRN) a year ago would have delivered you a 46% gain

The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you...

Yahoo | August 23, 2023

THRN vs. HQY: Which Stock Should Value Investors Buy Now?

THRN vs. HQY: Which Stock Is the Better Value Option?

Yahoo | August 21, 2023

Thorne HealthTech Reports Second Quarter 2023 Results

Thorne HealthTech, Inc. ("Thorne HealthTech", "Thorne" or the "Company") (NASDAQ: THRN), a leader in delivering personalized, innovative solutions that empower individuals to live healthier, longer lives, today announced its financial results for the second quarter ended June 30, 2023.

Yahoo | August 8, 2023

Thorne HealthTech Schedules Second Quarter 2023 Earnings Release and Conference Call for August 8

Thorne HealthTech, Inc. (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, will release its second quarter 2023 financial results after market close on Tuesday, Aug. 8, 2023. The company will host a conference call to discuss its results on Tuesday, Aug. 8, 2023, at 5:00 p.m. (U.S. Eastern Time).

Yahoo | August 1, 2023

Thorne HealthTech to Participate in the Canaccord Genuity 43rd Annual Growth Conference on August 10

Thorne HealthTech, Inc. ("Thorne") (the "Company") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, announced today that it will participate in the Canaccord Genuity 43rd Annual Growth Conference in Boston.

Yahoo | July 28, 2023

THORNE LAUNCHES GLOBAL CAMPAIGN - BUILD TO LAST - WITH FATHER AND SON DUO DWYANE AND ZAIRE WADE

Thorne HealthTech, Inc. ("Thorne") (NASDAQ: THRN), a leader in delivering innovative solutions for a personalized approach to health and wellness, today announced its Build to Last campaign, featuring three-time NBA Champion, philanthropist, and entrepreneur, Dwyane Wade and his son and professional basketball player, Zaire Wade.

Yahoo | July 25, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!